Literature DB >> 6812405

Long-term follow-up of verapamil and nitrate treatment for coronary artery spasm.

S B Freedman, D R Richmond, D T Kelly.   

Abstract

Thirty-seven patients with coronary artery spasm and minor coronary atherosclerosis (34) or normal coronary arteries (3) were followed up long-term. All had angina at rest, 32 had nocturnal angina, and 13 had a positive exercise test with S-T elevation. Three had a previous subendocardial infarction; 10 had had serious arrhythmias, which caused syncope in 7. At last review, 21 months (range 1 to 61) after starting therapy, 27 patients continued on verapamil, 314 (120 to 600) mg/day; 4 who did not respond to verapamil were taking nifedipine, 58 (30 to 80) mg/day; and 16 were also taking isosorbide dinitrate, 41 (20 to 80) mg/day. Of the 31 patients on therapy, 21 were asymptomatic, 9 were improved (1 to 4 attacks/month), and 1 had an average of 8 anginal attacks/month; the remaining 6 had stopped therapy and 5 were asymptomatic a mean of 10 (3 to 18) months after stopping. The exercise test became negative in all 12 patients tested on therapy, although 3 required nitrates in addition to verapamil or nifedipine. In 26 supervised treatment withdrawals in the hospital, a mean of 15 (1 to 55) months on therapy, 10 developed angina in less than 48 hours. Angina recurred in all 6 unsupervised, patient-initiated withdrawals. Failure to stop smoking was positively associated with recurrence of angina on treatment withdrawal (p less than 0.02). Long-term treatment of coronary artery spasm with verapamil or nifedipine together with isosorbide dinitrate was well tolerated and effectively relieved angina. No documented serious arrhythmias, syncopal episodes, myocardial infarction, or death occurred during follow-up.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6812405     DOI: 10.1016/0002-9149(82)91223-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Isosorbide dinitrate attenuated coronary artery spasm during general anesthesia for non-cardiac surgery.

Authors:  H Komatsu; H Mitsuhata; S Matsumoto; J Hasegawa
Journal:  J Anesth       Date:  1993-07       Impact factor: 2.078

2.  Coronary artery spasm: a rare cause of syncope.

Authors:  M E W Hemels; A C P Wiesfeld; F van den Berg; F Zijlstra; I C van Gelder
Journal:  Neth Heart J       Date:  2005-01       Impact factor: 2.380

3.  Long lasting spasticity in controlled vasospastic angina.

Authors:  O Ueda; K Kohchi; Y Kishi; F Numano
Journal:  Heart       Date:  1999-05       Impact factor: 5.994

Review 4.  Combination of nitrates with other antianginal drugs.

Authors:  K E Andersson; P Hoglund
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Rebound of vasospastic angina after cessation of long-term treatment with nifedipine.

Authors:  J Lette; R M Gagnon; J G Lemire; M Morissette
Journal:  Can Med Assoc J       Date:  1984-05-01       Impact factor: 8.262

Review 6.  Post-valvular surgery multi-vessel coronary artery spasm - A literature review.

Authors:  Francesco Formica; Oluwaseun Adebayo Bamodu; Serena Mariani; Giovanni Paolini
Journal:  Int J Cardiol Heart Vasc       Date:  2015-10-30

7.  Verapamil and vasospastic angina: underuse in the elderly population.

Authors:  Xavier Humbert; Vincent Roule; Paul Milliez; Joachim Alexandre
Journal:  J Geriatr Cardiol       Date:  2017-07       Impact factor: 3.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.